Clarity in ex-vivo cardiac transport system naming conventions

Le résumé fourni par la source

Solid organ transplantation has advanced to include a panoply of organ transport techniques designed to protect organ allografts from ischemia and ischemia-reperfusion injury. Heart transplantation includes a variety of stakeholders with proprietary interests in distinguishing a particular device, transportation strategy, or cardioprotective or cardioplegic agent from its competing alternatives. This may be undertaken in either an “open source” or “copyleft” approach, for the ongoing and broad benefit of the transplant community as a whole, or may reflect a restrictive approach including trademarks and patent protection claims for intellectual property.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.